2005 Consecutively succeeded in transplantation to adult leukemia
patients using cord blood stem cells

2007 Developed new stem cell technology/genetically
modified human embryonic stem cell lines

2009 Approved research on somatic cell cloning
embryonic stem cells derived from somatic
cells for the first time in Korea / Treated a
cerebral palsy patient through Korea’s first
cord blood stem cell transplantation /
Established induced pluripotent stem cells
using protein only for the first time in world
history

2010 Secured embryonic stem cell lines
implantable to 25% of the Korean population

2011 2011 Clinically approved Korea’s first
embryonic stem cell therapy for
Stargardt's disease

2012 Clinically approved Korea’s first senile
macular degeneration derived from
embryonic stem cells / Suggested a
possible approach to treating
Huntington’s disease using stem cells for
the first time in world history

2013 Successfully treated cerebral palsy using
other’s cord blood stem cells for the first time
in world history/ Clinically approved Korea’s
first myopic retinal degeneration medicine
derived from embryonic stem cells

2014 Established cloned stem cell lines using
adult somatic stem cells for the first time
in the world

2015 Published a clinical paper on the embryonic stem cell-derived
retina disease medicine in 2015 for the first time in Asia